References
- American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 201: pregestational diabetes mellitus. Obstet Gynecol. 2018;132(6):e228–e248.
- American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49–e64.
- Peterson C, Grosse SD, Li R, et al. Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States. Am J Obstet Gynecol. 2015;212(1):74.e1–74.e9.
- Diabetes in pregnancy. Center for Disease Control, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion; 2018.
- Ehrenberg HM, Durnwald CP, Catalano P, et al. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol. 2004;191(3):969–974.
- Zeki R, Oats J, Wang A, et al. Cesarean section and diabetes during pregnancy: an NSW population study using the Robson classification. J Obstet Gynaecol Res. 2018;44(5):890–898.
- Blackwell SC, Hassan SS, Wolfe HW, et al. Why are cesarean delivery rates so high in diabetic pregnancies? J Perinat Med. 2000;28(4):316–320.
- Campbell S, Murphy M, Keane D, et al. Classification of intrapartum cesarean delivery: a starting point for more detailed analysis. Am J Obstet Gynecol. 2017;216(1):S245–S246.
- Robson MS. Classification of caesarean sections. Fet Matern Med Rev. 2001;12(1):23–39.
- Robson M, Murphy M, Byrne F. Quality assurance: the 10-group classification system (Robson classification), induction of labor, and cesarean delivery. Int J Gynaecol Obstet. 2015;131(Suppl. 1):S23–S27.
- Robson MS. The 10-group classification system – a new way of thinking. Am J Obstet Gynecol. 2018;219(1):1–4.
- WHO. WHO statement on caesarean section rates. Department of Reproductive Health and Research, WHO; 2015.
- Kauffman E, Souter VL, Katon JG, et al. Cervical dilation on admission in term spontaneous labor and maternal and newborn outcomes. Obstet Gynecol. 2016;127(3):481–488.
- Duryea EL, Hawkins JS, McIntire DD, et al. A revised birth weight reference for the United States. Obstet Gynecol. 2014;124(1):16–22.
- Kjos SL, Berkowitz K, Xiang A. Independent predictors of cesarean delivery in women with diabetes. J Matern Fetal Neonatal Med. 2004;15(1):61–67.
- Martin JA, Hamilton BE, Osterman MJK, et al. Births: final data for 2019. Natl Vital Stat Rep. 2021;70(2):1–51.
- Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
- Naylor CD, Sermer M, Chen E, et al. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators. JAMA. 1996;275(15):1165–1170.
- Inocêncio G, Braga A, Lima T, et al. Which factors influence the type of delivery and cesarean section rate in women with gestational diabetes? J Reprod Med. 2015;60(11–12):529–534.
- Palatnik A, Swanson K, Churchill T, et al. Association between type of screening for gestational diabetes mellitus and cesarean delivery. Obstet Gynecol. 2017;130(3):539–544.
- Gabbe SG, Mestman JH, Freeman RK, et al. Management and outcome of pregnancy in diabetes mellitus, classes B to R. Am J Obstet Gynecol. 1977;129(7):723–729.
- Ali DS, Davern R, Rutter E, et al. Pre-Gestational diabetes and pregnancy outcomes. Diabetes Ther. 2020;11(12):2873–2885.
- Gunton JE, McElduff A, Sulway M, et al. Outcome of pregnancies complicated by pre-gestational diabetes mellitus. Aust N Z J Obstet Gynaecol. 2000;40(1):38–43.
- Dharan VB, Srinivas SK, Parry S, et al. Pregestational diabetes: a risk factor for vaginal birth after cesarean section failure? Am J Perinatol. 2010;27(3):265–270.
- Blackwell SC, Hassan SS, Wolfe HM, et al. Vaginal birth after cesarean in the diabetic gravida. J Reprod Med. 2000;45(12):987–990.
- Gregory KD, Korst LM, Fridman M, et al. Vaginal birth after cesarean: clinical risk factors associated with adverse outcome. Am J Obstet Gynecol. 2008;198(4):452.e1–452.e10.
- Goldman M, Kitzmiller JL, Abrams B, et al. Obstetric complications with GDM. Effects of maternal weight. Diabetes. 1991;40(Suppl. 2):79–82.
- Langer O, Yogev Y, Xenakis EM, et al. Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am J Obstet Gynecol. 2005;192(6):1768–1776.
- Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–2486.
- Bramham K, Parnell B, Nelson-Piercy C, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348(7):g2301.
- Leach L, Taylor A, Sciota F. Vascular dysfunction in the diabetic placenta: causes and consequences. J Anat. 2009;215(1):69–76.
- Vambergue A, Fajardy I. Consequences of gestational and pregestational diabetes on placental function and birth weight. World J Diabetes. 2011;2(11):196–203.
- Mackin ST, Nelson SM, Wild SH, et al. Factors associated with stillbirth in women with diabetes. Diabetologia. 2019;62(10):1938–1947.
- Starikov R, Dudley D, Reddy UM. Stillbirth in the pregnancy complicated by diabetes. Curr Diab Rep. 2015;15(3):11.
- Al-Qahtani S, Heath A, Quenby S, et al. Diabetes is associated with impairment of uterine contractility and high caesarean section rate. Diabetologia. 2012;55(2):489–498.
- Favaro RR, Salgado RM, Raspantini PR, et al. Effects of long-term diabetes on the structure and cell proliferation of the myometrium in the early pregnancy of mice. Int J Exp Pathol. 2010;91(5):426–435.
- Mitidieri E, Vanacore D, Turnaturi C, et al. Uterine dysfunction in diabetic mice: the role of hydrogen sulfide. Antioxidants. 2020;9(10):917.
- Favaro RR, Morales-Prieto DM, Herrmann J, et al. Influence of high glucose in the expression of miRNAs and IGF1R signaling pathway in human myometrial explants. Arch Gynecol Obstet. 2021;303(6):1513–1522.
- Hawkins JS, Stephenson M, Powers B, et al. Diabetes mellitus: an independent predictor of duration of prostaglandin labor induction. J Perinatol. 2017;37(5):488–491.
- Frey HA, Tuuli MG, England SK, et al. Factors associated with higher oxytocin requirements in labor. J Matern Fetal Neonatal Med. 2015;28(13):1614–1619.
- Kenyon S, Armstrong N, Johnston T, et al. Standard- or high-dose oxytocin for nulliparous women with confirmed delay in labour: quantitative and qualitative results from a pilot randomised controlled trial. BJOG. 2013;120(11):1403–1412.
- Son M, Roy A, Stetson BT, et al. High-dose compared with standard-dose oxytocin regimens to augment labor in nulliparous women: a randomized controlled trial. Obstet Gynecol. 2021;137(6):991–998.
- Dude AM, Grobman WA, Yee LM. Association between sonographic estimated fetal weight and the risk of cesarean delivery among nulliparous women with diabetes in pregnancy. Am J Perinatol. 2018;35(13):1297–1302.